CELLCEUTIX Share Price OTC Bulletin Board
Equities
CTIX
US15115V1017
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
01/02 | Innovation Pharmaceuticals Inc. Announces Resignation of Board Members | CI |
2023 | Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement | CI |
Sales 2022 | 0.02 1.5 | Sales 2023 | - | Capitalization | 1.04Cr 87Cr |
---|---|---|---|---|---|
Net income 2022 | -70L -58Cr | Net income 2023 | -30L -25Cr | EV / Sales 2022 | 67,33,26,722 x |
Net cash position 2022 | 25.19L 21Cr | Net cash position 2023 | 8L 6.62Cr | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.22
x | P/E ratio 2023 |
-3.19
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.87% |
Managers | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 20/07/20 |
Jane Harness
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 20/07/20 |
1st Jan change | Capi. | |
---|---|---|
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.22TCr | |
-2.77% | 2.13TCr | |
-5.99% | 1.9TCr | |
-35.21% | 1.85TCr | |
-10.86% | 1.68TCr | |
+37.57% | 1.25TCr | |
-26.24% | 808.97Cr |
- Stock Market
- Equities
- IPIX Stock
- CTIX Stock